Specificity of clinical breast examination in community practice

Journal of General Internal Medicine

Volumn 22, Issue 3, 2007, Pages 332-337

  Fenton, Joshua J ^a   Rolnick, Sharon J ^b   Harris, Emily L ^c   Barton, Mary B ^d   Barlow, William E ^e   Reisch, Lisa M ^f   Herrinton, Lisa J ^g   Geiger, Ann M ^h   Fletcher, Suzanne W ^d   Elmore, Joann G ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Health Partners   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d Harvard Pilgrim Healthcare ^*  (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g DIVISION OF RESEARCH   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Physical examination; Screening; Sensitivity and specificity

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER RISK; CLINICAL EXAMINATION; CLINICAL PRACTICE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; MEDICAL RECORD; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BREAST TUMOR; COHORT ANALYSIS; COMMUNITY CARE; COMPARATIVE STUDY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PHYSICAL EXAMINATION; PHYSICIAN;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; COMMUNITY HEALTH SERVICES; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PHYSICAL EXAMINATION; PHYSICIANS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 34250310452     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-006-0062-7     Document Type: Article

References (25)

1. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003;53:141-69.
2. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening. Summary of the evidence. Ann Intern Med. 2002;137:344-6.
3. Meissner HI, Breen N, Yabroff KR. Whatever happened to clinical breast examinations? Am J Prev Med. 2003;25:259-63.
4. Coughlin SS, Uhler RJ, Bobo JK, Caplan L. Breast cancer screening practices among women in the United States, 2000. Cancer Causes Control. 2004;15:159-70.
5. Mittra I. Early detection of breast cancer in industrially developing countries. Gan To Kagaku Ryoho. 1995;22(suppl 3):230-5.
6. Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 1999;282:1270-80.
7. Bobo JK, Lee NC, Thames SF. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst. 2000;92:971-6.
8. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165-75.
9. Oestreicher N, White E, Lehman CD, Mandelson MT, Porter PL, Taplin SH. Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res Treat. 2002;76:73-81.
10. Fenton JJ, Barton MB, Geiger AM, et al. Screening clinical breast examination: how often does it miss lethal breast cancer? J Natl Cancer Inst Monogr. 2005(35):67-71.
11. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examination. N Engl J Med. 1998;338:1089-96.
12. Oestreicher N, Lehman CD, Seger DJ, Buist DS, White E. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. AJR Am J Roentgenol. 2005;184:28-32.
13. Kahn KL, Goldberg RJ. Screening for breast cancer in the ambulatory setting. Clin Res. 1984;32:649A.
14. Fletcher SW, O'Malley MS, Bunce LA. Physicians' abilities to detect lumps in silicone breast models. JAMA. 1985;253:2224-8.
15. Wagner EH, Greene SM, Hart G, et al. Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr. 2005(35):3-11.
16. Elmore JG, Reisch LM, Barton MB, et al. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst. 2005;97:1035-43.
17. Reisch LM, Fosse JS, Beverly K, et al. Training, quality assurance, and assessment of medical record abstraction in a multisite study. Am J Epidemiol. 2003;157:546-51.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
19. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;4:695-702.
20. McDonald S, Saslow D, Alciati MH. Performance and reporting of clinical breast examination: a review of the literature. CA Cancer J Clin. 2004;4:345-61.
21. American Cancer Society. Cancer Facts and Figures, 2003. Available from: http://www.cancer.org/downloads/STT/CancerFacts&Figures2002TM.pdf. Accessed on April 29, 2004.
22. Baines CJ, Miller AB, Bassett AA. Physical examination: its role as a single screening modality in the Canadian National Breast Screening Study. Cancer. 1989;63:1816-22.
23. Saslow D, Hannan J, Osuch J, et al. Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin. 2004;54:327-44.
24. Elmore JG, Wells CK, Howard DH, Feinstein AR. The impact of clinical history on mammographic interpretations. JAMA. 1997;277:49-52.
25. Barton MB, Elmore JG, Fletcher SW. Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med. 1999;130:651-7.